En Es
Categories

Industry News

Global Electrosurgery Market to Reach Almost USD 6 Billion by 2026

By HospiMedica International staff writers
22 Apr 2022

Image: Rising number of surgeries is driving the electrosurgery market (Photo courtesy of Pexels)

Electrosurgery makes use of high frequency electrical energy for carrying out high precision surgeries, while ensure low levels of tissue damage and less oxygen sacrifice. Electrosurgical procedures are widely used in medical disciplines such as gynecology, urology, pneumology, neurology, abdominal surgery, general surgery, and gastroenterology among others. The faster recovery time, low risk to patients, easy usage, and reduced risk of infection are some of the advantages driving the use of electrosurgery procedures as compared to traditional surgical techniques. The global electrosurgery market is projected to grow at a CAGR of 3.6% from an estimated USD 5 billion in 2022 to almost USD 6 billion by 2026, driven by the rapidly rising number of surgeries being performed globally, an aging population, and increasing prevalence of various chronic diseases.


These are the latest findings of Global Industry Analysts Inc. (San Jose, CA, USA), a market research company.


The growing geriatric population worldwide, with higher susceptibility to diseases such as cardiac arrest, cancer, intestinal and gastrointestinal diseases owing to their weakening immune system, is emerging as the key driver of the demand for electrosurgery procedures and devices. The incidence of chronic diseases continues to increase, necessitating surgical intervention is paving the way for electrosurgical devices to be used. The increasing number of minimally invasive surgeries being performed is enhancing the significance of the electrosurgery technique in critical surgical methods such as cutting, coagulation, devitalization and thermofusion.


Increasing number of cosmetic and plastic surgeries being carried out and the rapid pace of technology advancements in electrosurgical tools are also favoring the growth of the electrosurgery market. Advancements in the electrosurgical technology space are primarily focused on achieving anatomic dissection with improved precision, better hemostasis, and minimum thermal damage to the surrounding tissue. Other areas include improved cutting precision, minimizing the occurrence of tissue adhesion to the electrode device, and temperature regulation electrode-tissue contact area. The recent years have witnessed the rollout of devices with high radiofrequency, embedded digital algorithms to control the impact of delivered energy, and hybrid technologies that combine the benefits of both bipolar and ultrasonic technology.


In North America, the expanding geriatric population and rapidly rising demand for cosmetic surgeries is fueling growth of the region’s electrosurgery market. The established and advanced nature of its healthcare industry and favorable government policies are spurring the growth of the North American electrosurgery market. The US represents the largest regional market for electrosurgery and is projected to reach USD 2 billion by 2026 from an estimated USD 1.8 billion in 2022.


The electrosurgery market in Asia-Pacific is poised to grow at fast pace, mainly due to rising demand for plastic and cosmetic surgeries in the region. Growing awareness about minimally invasive surgeries is also fueling the demand for electrosurgery instruments in the region. The growing demand for elective cosmetic surgeries, increasing access to elective surgeries, improving healthcare infrastructure facilities, and better insurance coverage are also driving the growth of the Asia-Pacific electrosurgery market. China is expected to spearhead the growth of the global electrosurgery market and emerge as the fastest growing regional market with a CAGR of 4.4% over the forecast period.


Related Links:
Global Industry Analysts Inc. 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

27 Jun 2022
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.
Read More
24 Jun 2022
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031
The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.
Read More
21 Jun 2022
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Read More
21 Jun 2022
Global Bedside Testing Market to Witness Promising Prospects in Critical Care
Point-of-care or point-of-use diagnostics, also known as bedside testing, has gained increased prominence in analytical testing over the past few years as it provides clinically relevant information without the need for a dedicated laboratory.
Read More
20 Jun 2022
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth.
Read More
14 Jun 2022
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover.
Read More
14 Jun 2022
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions